CLGN CollPlant Ltd Net Income

Corporate emblem and logo of CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies is creating monopoly potential through its patented plant-based collagen for 3D bioprinting. Professional Israeli management is optimizing expenses, as evidenced by the company's total profit, which stood at -0.01. However, intense competition in regenerative medicine and the expansion of industry behemoths create risks of the startup's intellectual property being absorbed.

Company Net Income: CollPlant Biotechnologies (CLGN) for 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for collplant.com (CLGN)

- share price and expert price forecast:
Price CollPlant Biotechnologies Ltd.|CLGN - Price Target Chart
- market capitalization data:
Market Valuation CLGN|CLGN - Enterprise Value
- company book value details:
Net Asset Value per Share CollPlant Biotechnologies|CLGN - Company Book Value|Capitalization to Book Value Ratio collplant.com|CLGN - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital CollPlant Biotechnologies|CLGN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio CollPlant Biotechnologies Ltd.|CLGN - Company Debts|Debts to Book Value CLGN|CLGN - Company Long-Term Debt|Company Short-Term Debt CollPlant Biotechnologies|Quick Liquidity collplant.com
- company profitability and valuation multiples indicators:
CLGN - Company Net Income
Basic company analysis:CLGN CollPlant Ltd
Flagship merchandise of CollPlant

The scaling of the rhCollagen platform within the bioprinting and aesthetic medicine segments is directly reflected in the financial profit dynamics of CollPlant Biotechnologies (CLGN). This indicator measures the daily efficiency of capital utilization, uncovering hidden management vulnerabilities beyond market noise, which allows investors to assess the actual quality of operational growth and the long-term resilience of the business against potential drawdowns.

Main competitors

HCA: Profit After Payment of Taxes|Company Net Income Tenet Healthcare|Net Income freseniusmedicalcare.com (FMS)|Net Profit SOLV|EHC - Company Net Income|Company Net Income Universal Health Services, Inc. UHS|DVA: Company Profit|RDNT: Net Income|optioncarehealth.com - Profit After Payment of Taxes|SGRY: Net Profit|Net Income Premier Inc|Company Net Income National Vision Corp|Company Net Income Progyny Corp PGNY|Company Net Income Ardent Health Partners, Inc. (ARDT)|Company Net Income SEM (selectmedical.com)|Company Net Income Astrana Health ASTH|MEDNAX - Company Net Income|USPH - Company Net Income|Profit After Tax PNTG|Organogenesis Holdings (ORGO) - Company Net Income|NUTX (nutexhealth.com) - Company Net Income|AUNA (Auna) - Net Profit|Net Profit SBC Medical Group Holdings|Company Net Income Jeuveau (EOLS)|Community Health Corp - Company Profit|BeautyHealth - Net Income|Profit After Payment of Taxes MDWD (MediWound Ltd)|BTMD: Net Income|Final Profit JYNT (The Joint Corp)|DCGO: Net Profit|PIII (P3 Health Partners) - Company Net Income|GANX (Gain Therapeutics, Inc.) - Net Profit|euda.com (EUDA) - Net Financial Result|Company Net Income Basel Medical Group (BMGL)|CUPR - Company Net Income|Concord Medical Services Holdings Limited - Net Income|Profit After Payment of Taxes AMS (ASHS)|MEDIROM - Net Profit|Company Net Income Avalon GloboCare|DHAI: Net Profit|Net Income Carmell Therapeutics Corporation|NIVF (NewGenIvf Group Ltd) - Net Profit|ATIP: Final Profit|Company Net Income CareMax, Inc. (CMAX)|kindlymd.com - Company Profit|Company Net Income ModivCare MODV|Novo Integrated Sciences Inc (NVOS) - Company Net Income|SSY - Company Net Income|BACK: Company Net Income